Cargando…
Structural Complementarity of Bruton’s Tyrosine Kinase and Its Inhibitors for Implication in B-Cell Malignancies and Autoimmune Diseases
Bruton’s tyrosine kinase (BTK) is a critical component in B-cell receptor (BCR) signaling and is also expressed in haematogenic and innate immune cells. Inhibition of BTK hyperactivity is implicated in B-cell malignancies and autoimmune diseases. This review derives the structural complementarity of...
Autores principales: | Najmi, Asim, Thangavel, Neelaveni, Mohanan, Anugeetha Thacheril, Qadri, Marwa, Albratty, Mohammed, Ashraf, Safeena Eranhiyil, Saleh, Safaa Fathy, Nayeem, Maryam, Mohan, Syam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051736/ https://www.ncbi.nlm.nih.gov/pubmed/36986499 http://dx.doi.org/10.3390/ph16030400 |
Ejemplares similares
-
Stroke-Induced Central Pain: Overview of the Mechanisms, Management, and Emerging Targets of Central Post-Stroke Pain
por: Mohanan, Anugeetha Thacheril, et al.
Publicado: (2023) -
Pharmacophore model-aided virtual screening combined with comparative molecular docking and molecular dynamics for identification of marine natural products as SARS-CoV-2 papain-like protease inhibitors
por: Thangavel, Neelaveni, et al.
Publicado: (2022) -
Benchmarked molecular docking integrated molecular dynamics stability analysis for prediction of SARS-CoV-2 papain-like protease inhibition by olive secoiridoids
por: Thangavel, Neelaveni, et al.
Publicado: (2023) -
Synthesis, molecular docking, and in vivo antidiabetic evaluation of new benzylidene-2,4-thiazolidinediones as partial PPAR-γ agonists
por: Najmi, Asim, et al.
Publicado: (2023) -
Bruton's tyrosine kinase: oncotarget in myeloma
por: Tai, Yu-Tzu, et al.
Publicado: (2012)